Director - Clinical Research Physician

Chester, Maryland, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a Medical Doctor or Doctor of Osteopathy degree and be board eligible or certified in Oncology or Hematology, or have equivalent post-medical school clinical training. A minimum of 5 years of experience in clinical trials or research within the pharmaceutical industry, academia, or a research setting is required. A PhD is highly advantageous, along with proven leadership, strong communication, and document management skills, including proficiency in MS Word, EndNote, PowerPoint, and Excel. The ability to multi-task, exercise judgment, and develop collaborative relationships is essential.

Responsibilities

The Senior Director of Clinical Development will lead clinical development programs, serving as a liaison to physicians and clinical trial sites. Key responsibilities include the design, analysis, interpretation, and reporting of scientific content for protocols, investigator brochures, clinical study reports, and regulatory submissions. This role involves contributing to due diligence, designing translational strategies, acting as a clinical lead, soliciting opinion leader interactions, and partnering with cross-functional teams. The position requires staying updated on therapeutic area advancements, representing Lilly at external meetings, understanding and complying with regulatory requirements, and ensuring adherence to Good Clinical Practices, pharmacovigilance standards, and operating procedures.

Skills

Clinical Development

Clinical Trial Design

Medical Writing

Regulatory Submissions

Translational Medicine

Opinion Leader Engagement

Cross-functional Team Leadership

Scientific Communication

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free